Stock listing

Skye Bioscience, Inc.

Selected listing: A3ES4X · LS · EUR · DE

Skye Bioscience, Inc. (Lang & Schwarz: A3ES4X), Health Technology. Latest release Aug 14, 2026: Skye Bioscience and Redx Pharma Announce Transaction Agreement…

A3ES4X:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A3ES4X
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Skye Bioscience, Inc.

Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings

August 14, 2026

SkyVolt Energy Signs LOI with Modular Data Center Company Nodiac.ai, Unlocking Potential Additional Revenue from strategic Existing and Future Energy Development Assets

June 18, 2026

Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1

May 20, 2026

UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update

May 12, 2026

Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update

May 11, 2026

All Skye Bioscience, Inc. news →

Events

Replays

Skye Bioscience, Inc. (SKYE) Q4 2025 Earnings Call
Tue, Mar 10, 2026 · 04:30 PM ET
Watch
Skye Bioscience, Inc. (SKYE) Q3 2025 Earnings Call
Mon, Nov 10, 2025 · 04:30 PM ET
Watch
Skye Bioscience, Inc. (SKYE) Q2 2025 Earnings Call
Thu, Aug 07, 2025 · 04:30 PM ET
Watch

Research Skye Bioscience, Inc.

Skye Bioscience, Inc. company profile

View the public company page for Skye Bioscience, Inc. on 6ix.

Skye Bioscience, Inc. news

Read company news and market updates connected to Skye Bioscience, Inc..

Skye Bioscience, Inc. investor events

Find investor webinars, events, and replay context for Skye Bioscience, Inc..